About Batavia Biosciences
Batavia Biosciences is a company based in Leiden (Netherlands) founded in 2010 by Chris Yallop and Menzo Havenga was acquired by CJ CheilJedang in November 2021. The company has 11 employees as of December 31, 2021. Batavia Biosciences offers products and services including Viral Vectors, Viral Vaccines, and HIP-Vax Technology. Batavia Biosciences operates in a competitive market with competitors including KBI Biopharma, EirGenix, Aldevron, Arranta Bio and Ovagen, among others.
- Headquarter Leiden, Netherlands
- Employees 11 as on 31 Dec, 2021
- Founders Chris Yallop, Menzo Havenga
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Batavia Bio Processing Limited
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$444.29 K (USD), Grant
May 01, 2023
-
Investors
Gates Foundation
& 3 more
-
Employee Count
11
as on Dec 31, 2021
-
Acquired by
CJ CheilJedang
(Nov 08, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Batavia Biosciences
Batavia Biosciences offers a comprehensive portfolio of products and services, including Viral Vectors, Viral Vaccines, and HIP-Vax Technology.
Development and manufacturing for gene therapy and delivery tools.
Process development for vaccine production and applications.
Platform for efficient polio and other vaccine manufacturing processes.
People of Batavia Biosciences
Unlock access to complete
Funding Insights of Batavia Biosciences
Investors in Batavia Biosciences
Batavia Biosciences has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include Gates Foundation, Path and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Charitable foundation investments on poverty reduction and healthcare
|
Locked | Locked | Locked | |
|
Global health solutions are developed and delivered to enhance outcomes.
|
Locked | Locked | Locked |
Investor details for Batavia Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Batavia Biosciences
Investment portfolio details for Batavia Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Batavia Biosciences
Detailed financials for Batavia Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Batavia Biosciences Comparisons
Peer comparison for Batavia Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Batavia Biosciences
Batavia Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as KBI Biopharma, EirGenix, Aldevron, Arranta Bio and Ovagen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of protein formulation, process & cell line development, and cGMP services
|
|
| Locked | Locked | Locked |
Biologics development and manufacturing services are offered by EirGenix.
|
|
| Locked | Locked | Locked |
Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications
|
|
| Locked | Locked | Locked |
Developer of therapeutics for microbiome based diseases
|
|
| Locked | Locked | Locked |
Provider of germ-free and specific pathogen free production of eggs for vaccine and antibody manufacturing services
|
|
| Locked | Locked | Locked |
Vaccines and biologics are developed and manufactured by IDT Biologika.
|
Detailed competitors of Batavia Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Batavia Biosciences
Complete news archive for Batavia Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Batavia Biosciences
Batavia Biosciences was founded in 2010 and raised its 1st funding round 6 years after it was founded.
Batavia Biosciences is headquartered in Leiden, Netherlands. It is registered at Leiden, South Holland, Netherlands.
Menzo Havenga is the current CEO of Batavia Biosciences. They have also founded this company.
As of Dec 31, 2021, the latest employee count at Batavia Biosciences is 11.
Batavia Biosciences is a CDMO engaged in the development of biopharmaceutical products such as proteins, antibodies, vaccines and viral vectors. They have a portfolio of technologies for improving product yield (STEP), to reduce process development time (SIDUS, SCOUT) and for improving product stability. Their STEP technology is a plasmid based expression platform that enables rapid mammalian CHO cell line generation and improved protein expression. Batavia claims that the STEP platform can offer up to 10-fold increase in protein expression and the stable cell clones can be generated in 14 weeks. They also have a transient production technology that can be used for producing clinical material (proteins) faster. The company claims to have expertise in upstream (mammalian, microbial and insect based platforms) and downstream processing, clinical and commercial manufacturing and also in DNA cloning and mammalian cell line generation.
Batavia Biosciences's top competitors include KBI Biopharma, Aldevron and Ovagen.
Batavia Biosciences offers Viral Vectors, Viral Vaccines, and HIP-Vax Technology.
Batavia Biosciences has 4 investors. Key investors include Gates Foundation, Path, European Union, and CJ CheilJedang.